Oncology
Consultant Medical Oncologist18 years of experience in oncology.
HCG Cancer Center
Kalaburagi
Dr. Nandish Kumar Jeevangi is a Consultant Medical Oncologist practising in Gulbarga, also known as Kalaburagi, Karnataka. He is currently associated with HCG Cancer Center, Gulbarga, where he provides medical oncology consultation and treatment for patients diagnosed with different types of cancer.
He holds MBBS and MD in General Medicine qualifications and completed his DM in Medical Oncology from Tata Memorial Centre, Mumbai, in 2010. His specialised training in medical oncology enables him to manage cancers using systemic treatments such as chemotherapy, targeted therapy, immunotherapy and other medicine-based cancer treatments.
Dr. Nandish Kumar Jeevangi has more than 18 years of professional experience in oncology. His previous professional experience includes working as a Registrar in Medical Oncology at Tata Memorial Hospital and as a Consultant in Medical Oncology at Yashoda Hospitals before joining HCG Cancer Center, Gulbarga.
His areas of clinical care include breast cancer, lung cancer, blood cancers, lymphoma, liver cancer, oral cancer and other solid and haematological malignancies. Treatment recommendations are planned according to the type of cancer, disease stage, molecular characteristics, previous treatments and the patient's overall health.
As a Medical Oncologist, Dr. Nandish Kumar Jeevangi focuses on personalised cancer treatment and coordinates with surgical oncologists, radiation oncologists and other specialists when multidisciplinary cancer care is required.
Patients looking for a Medical Oncologist in Gulbarga or Kalaburagi can consult Dr. Nandish Kumar Jeevangi for cancer evaluation, chemotherapy planning, systemic cancer treatment, treatment monitoring and follow-up care.
Medical oncology consultation involves evaluating the cancer diagnosis, biopsy findings, imaging reports, disease stage and overall health to develop an appropriate medicine-based cancer treatment plan.
Chemotherapy uses anti-cancer medicines to destroy or control cancer cells. The medicines, dosage and treatment schedule are selected according to the cancer type, stage and individual patient requirements.
Targeted therapy uses medicines designed to act on specific molecular changes or proteins involved in cancer growth. Biomarker or molecular testing may be required before selecting suitable targeted treatments.
Immunotherapy works by helping the body's immune system recognise and attack cancer cells. Suitability depends on the cancer type, stage, biomarkers and previous treatments.
Medical treatment for breast cancer may include chemotherapy, hormonal therapy, targeted therapy or immunotherapy depending on the tumour subtype, stage and receptor status.
Lung cancer treatment may involve chemotherapy, targeted medicines or immunotherapy based on the cancer subtype, molecular test results, disease stage and patient's overall condition.
Medical management of blood cancers may involve chemotherapy, targeted medicines, immunotherapy and other systemic treatments according to the specific type and progression of the disease.
Lymphoma treatment is planned according to whether the disease is Hodgkin or non-Hodgkin lymphoma, its subtype, stage and individual clinical factors.
Medical management of liver cancer may include systemic targeted therapy, immunotherapy or other cancer medicines depending on tumour characteristics, disease stage and liver function.
Medical oncology treatment for oral cancers may include chemotherapy, targeted therapy or immunotherapy, either alone or in combination with surgery and radiation therapy according to the stage of disease.
Systemic treatment for gastrointestinal cancers may involve chemotherapy, targeted therapy or immunotherapy depending on the affected organ, tumour biology and disease stage.
Bone marrow aspiration is a diagnostic procedure used to examine bone marrow cells when evaluating certain blood disorders, blood cancers and treatment responses.
Bone marrow transplant evaluation determines whether transplantation may be appropriate for selected blood cancers and related conditions based on diagnosis, disease status and overall patient fitness.
A peripherally inserted central catheter or PICC line may be used to safely administer repeated chemotherapy, medicines or supportive treatments over an extended period.
Cancer follow-up includes monitoring treatment response, reviewing investigations, managing treatment-related side effects and assessing patients for recurrence or disease progression.
MBBS, MD – General Medicine, DM – Medical Oncology
Medical Oncologist & Cancer Specialist
Genuine patient experiences and treatment feedback.
Quick answers to common questions about Dr. Nandish Kumar Jeevangi
Dr. Nandish Kumar Jeevangi specialises in Medical Oncology and provides medicine-based treatment for different types of cancer.
He currently practises at HCG Cancer Center in Gulbarga, Karnataka.
Yes. Medical oncology treatment for breast cancer may include chemotherapy, hormonal therapy, targeted therapy and immunotherapy depending on the cancer subtype and stage.
Yes. He provides medical oncology evaluation and treatment planning for lung cancer, including systemic therapies when clinically appropriate.
Yes. His oncology practice includes the medical management of blood cancers and lymphoma.
Contact us for personalized help or to schedule an appointment.